Ipilimumab (Yervoy) for Metastatic Melanoma

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2011年 / 53卷 / 1367期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：51 / 52
页数：2
相关论文
共 50 条
  • [21] Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
    Hodi, F. Stephen
    O'Day, Steven J.
    McDermott, David F.
    Weber, Robert W.
    Sosman, Jeffrey A.
    Haanen, John B.
    Gonzalez, Rene
    Robert, Caroline
    Schadendorf, Dirk
    Hassel, Jessica C.
    Akerley, Wallace
    van den Eertwegh, Alfons J. M.
    Lutzky, Jose
    Lorigan, Paul
    Vaubel, Julia M.
    Linette, Gerald P.
    Hogg, David
    Ottensmeier, Christian H.
    Lebbe, Celeste
    Peschel, Christian
    Quirt, Ian
    Clark, Joseph I.
    Wolchok, Jedd D.
    Weber, Jeffrey S.
    Tian, Jason
    Yellin, Michael J.
    Nichol, Geoffrey M.
    Hoos, Axel
    Urba, Walter J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08): : 711 - 723
  • [22] Clinical Activity of Ipilimumab for Metastatic Uveal Melanoma
    Luke, Jason J.
    Callahan, Margaret K.
    Postow, Michael A.
    Romano, Emanuela
    Ramaiya, Nikhil
    Bluth, Mark
    Giobbie-Hurder, Anita
    Lawrence, Donald P.
    Ibrahim, Nageatte
    Ott, Patrick A.
    Flaherty, Keith T.
    Sullivan, Ryan J.
    Harding, James J.
    D'Angelo, Sandra
    Dickson, Mark
    Schwartz, Gary K.
    Chapman, Paul B.
    Wolchok, Jedd D.
    Hodi, F. Stephen
    Carvajal, Richard D.
    CANCER, 2013, 119 (20) : 3687 - 3695
  • [23] Successful Combination of Electrochemotherapy and Ipilimumab in Metastatic Melanoma
    Hauptmann, N.
    Schaefer, S.
    Hauschild, A.
    Kaehler, K. C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 17 - 17
  • [24] Ipilimumab improves survival in metastatic melanoma patients
    Hodi, F. S.
    O'Day, S. J.
    McDermott, D. F.
    IMMUNOTHERAPY, 2011, 3 (08) : 928 - 929
  • [25] Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain Reply
    Tawbi, Hussein A.
    Chung, Caroline
    Margolin, Kim
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2178 - 2178
  • [26] A prognostic model for metastatic melanoma treated with ipilimumab
    Valpione, S.
    Piccin, L.
    Stragliotto, S.
    Pigozzo, J.
    Campana, L. G.
    Chiarion-Sileni, V.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S869 - S869
  • [27] Meningoencephalitis Following Ipilimumab Administration in Metastatic Melanoma
    Stein, Matthew K.
    Summers, Bryant B.
    Wong, Christine A.
    Box, Hilary L.
    Cleveland, Kerry O.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2015, 350 (06): : 512 - 513
  • [28] Ipilimumab: showing survival benefit in metastatic melanoma
    Minchom, Anna
    Young, Kate
    Larkin, James
    FUTURE ONCOLOGY, 2011, 7 (11) : 1255 - 1264
  • [29] Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
    Tawbi, Hussein A.
    Forsyth, Peter A.
    Algazi, Alain
    Hamid, Omid
    Hodi, F. Stephen
    Moschos, Stergios J.
    Khushalani, Nikhil I.
    Lewis, Karl
    Lao, Christopher D.
    Postow, Michael A.
    Atkins, Michael B.
    Ernstoff, Marc S.
    Reardon, David A.
    Puzanov, Igor
    Kudchadkar, Ragini R.
    Thomas, Reena P.
    Tarhini, Ahmad
    Pavlick, Anna C.
    Jiang, Joel
    Avila, Alexandre
    Demelo, Sheena
    Margolin, Kim
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (08): : 722 - 730
  • [30] Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma
    Nyakas, M.
    Aamdal, E.
    Jacobsen, K. D.
    Guren, T. K.
    Aamdal, S.
    Hagene, K. T.
    Brunsvig, P.
    Yndestad, A.
    Halvorsen, B.
    Tasken, K. A.
    Aukrust, P.
    Maelandsmo, G. M.
    Ueland, T.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2019, 197 (01): : 74 - 82
12345